Researchers apply EPO to investigate its high-affinity binding to the EPO receptor (EPOR), initiating JAK2-mediated signalling cascades that promote erythroid cell survival and differentiation. Pre-clinical observations in hematopoietic progenitor cultures indicate stimulation of red blood cell production, while non-hematopoietic models demonstrate anti-apoptotic effects and tissue preservation under ischemic or oxidative stress.
This recombinant glycoprotein facilitates examination of receptor dimerization, STAT5-dependent gene transcription, and selective pathway activation in erythropoiesis and tissue protection research.
Scientific Overview of EPO Applications
Pre-clinical models illustrate EPO’s engagement with receptor-mediated mechanisms:
- Activation of EPOR on erythroid progenitors, promoting proliferation and differentiation through JAK2/STAT5 signaling in hematopoietic cell systems.
- Enhancement of red blood cell production and reticulocyte release in anemic animal models.
- Cytoprotective effects in neuronal and cardiac tissue under ischemia or hypoxia, reducing infarct size and apoptotic signaling. https://pubmed.ncbi.nlm.nih.gov/10841560/
- Modulation of inflammatory and oxidative stress responses in brain and heart models via non-hematopoietic EPOR pathways. https://pubmed.ncbi.nlm.nih.gov/15803160/
- Support for investigations into tissue-specific protective signaling independent of erythropoiesis in stroke and myocardial injury paradigms.
- Examination of receptor heterodimer formation (e.g., EPOR-βcR) contributing to anti-apoptotic mechanisms in stress-challenged systems.
For additional context on EPO receptor signaling, erythroid differentiation, and cytoprotective pathways in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Why Investigators Select National Science Labs EPO
National Science Labs manufactures EPO under stringent GMP-compliant protocols to ensure batch-to-batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:
- Purity ≥99.9% by HPLC and SDS-PAGE
- Structural identity and glycosylation profile confirmation via mass spectrometry
- Complete Certificate of Analysis (CoA) documentation provided per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this peptide have not been evaluated by the FDA.
Initiate Your EPO Research Protocol
Source high-purity EPO from current limited batches to ensure optimal stability and performance in EPO receptor and cytoprotective signaling studies.
